SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-263605
Filing Date
2014-07-09
Accepted
2014-07-09 07:00:30
Documents
8
Period of Report
2014-07-09

Document Format Files

Seq Description Document Type Size
1 6-K d753530d6k.htm 6-K 12683
2 EX-99.1 d753530dex991.htm EX-99.1 483329
3 EX-99.2 d753530dex992.htm EX-99.2 125478
4 EX-99.3 d753530dex993.htm EX-99.3 30868
5 EX-99.4 d753530dex994.htm EX-99.4 10053
6 EX-99.5 d753530dex995.htm EX-99.5 10493
7 GRAPHIC g753530g53d04.jpg GRAPHIC 10084
8 GRAPHIC g753530g92f10.jpg GRAPHIC 21879
  Complete submission text file 0001193125-14-263605.txt   718223
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 14966356
SIC: 2834 Pharmaceutical Preparations